UHPLC and HPLC resale agreement

Article

LCGC Europe eNews

LCGC Europe eNewsLCGC Europe eNews-06-05-2009
Volume 0
Issue 0

PerkinElmer and LEAP Technologies have entered into a resale agreement for ultra high performance liquid chromatography (UHPLC) and high performance liquid chromatography (HPLC) technology.

PerkinElmer and LEAP Technologies have entered into a resale agreement for ultra high performance liquid chromatography (UHPLC) and high performance liquid chromatography (HPLC) technology. Under the arrangement, LEAP will be able to incorporate PerkinElmer's proprietary UHPLC and HPLC technology into the company's front-end automation systems for mass spectrometry within the US and Canada.

The combined offering is intended to enable LEAP's biotechnology and pharmaceutical customers to derive additional insight into the data of their most demanding applications. Financial details of the arrangement were not disclosed.

The arrangement will include PerkinElmer's Flexar and 200 series UHPLC and HPLC and the company's Chromera and TotalChrom chromatography data systems software packages and associated consumables and spare parts. It will also cover LEAP's CTC LC-1, HTC and HTS robotic sample handlers.

In addition, as a result of this arrangement, PerkinElmer will be able to provide advanced automation solutions from LEAP into markets beyond that company's traditional customer base, including environmental, food safety and forensics.

For more information about PerkinElmer visit www.perkinelmer.com
For more about LEAP technologies visit www.leaptec.com

Articles in this issue
Collaboration to explore FAIMS with TOF-MS
UHPLC and HPLC resale agreement
Related Videos
Toby Astill | Image Credit: © Thermo Fisher Scientific
Related Content
Estradiol generic estrogen Prescription Medicine Container with other prescription medication bottles in background | Image Credit: © Sherry Young - stock.adobe.com

LC–ESI-MS/MS Quantifies Estradiol with Reduced Reaction Time

April 23rd 2024
Article

The serum/plasma estradiol is useful for diagnosis, pathology, and therapeutic efficacy monitoring of estrogen-dependent diseases, according to the authors.

Katelyn Michael | Image courtesy of Katelyn Michael

Chromatography and PFAS Degradation Challenges: An Interview with Katelyn Michael

April 22nd 2024
Article

On the occasion of Earth Day, University of Wisconsin-Madison graduate student and chemist Katelyn Michael speaks with LCGC about the methods she has been using to attempt to degrade known PFAS.

Angela I. Calderón is a Gilliland Endowed Professor in the Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University. She received her B.S. in Pharmacy from the University of Panama, Panama City, Republic of Panama (1990), MSc. in Pharmacognosy from the University of Illinois at Chicago, Chicago, Illinois under the supervision of Dr. Djaja Djendoel Soejarto and Dr. Cindy K. Angerhofer (1997), and Ph.D. in Pharmacognosy from the University of Lausanne, Lausanne, Switzerland under the guidance of Prof. Kurt Hostettmann (2002). Then, she conducted her postdoctorate on biomedical applications of mass spectrometry at Prof. Richard B. van Breemen’s laboratory at the University of Illinois at Chicago (2006-2008). She joined the faculty at Auburn University College of Pharmacy as an Assistant Professor in August 2008. Dr. Calderón specializes in natural drug products research, specifically applications of mass spectrometry to natural products drug discovery, and quality and safety assessment of botanical dietary supplements. Over the last sixteen years, she has authored 52 publications, 1 US patent, and 5 book chapters. She also has received research funding from agencies that include National Center for Complementary and Integrative Health (NCCIH) and the Office of Dietary Supplements (ODS) of the National Institutes of Health (NIH), American Society of Pharmacognosy, United States Pharmacopeia, Auburn University Research Initiative in Cancer (AURIC), and botanical dietary supplements industry. Dr. Calderón is currently an expert member of the United States Pharmacopeia Botanical Pan-American Expert Panel. She also was a member of the United States Pharmacopeia Botanical Dietary Supplements and Herbal Medicines Expert Committee. Additionally, she was the Section Editor of Pharmacognosy of Combinatorial Chemistry & High Throughput Screening and Pharmaceutical Biology and is a current member of the Advisory Board of Planta Medica She has been grant proposal reviewer for National Institutes of Health (NIH), National Science Foundation (NSF), USA and German Federal Ministry of Education and Research (BMBF) and Project Management Jülich (PtJ) and Deutsche Forschungsgemeinschaft (German Research Foundation), Germany, and International Foundation for Science (IFS), Sweeden.

Angela Calderón Discusses Importance of Sustainable Analysis Techniques

April 22nd 2024
Article

In this interview, Angela Calderón of Auburn University discusses the importance of using more environmentally friendly analysis techniques.

Wonder Powder | Image Credit: © Shimadzu

Chromatography and Art Collide at Shimadzu Exhibit in Milan

April 20th 2024
Article

A 10-day exhibit at Milan Design Week in Italy is drawing to a close, but Shimadzu hopes that visitors have recognized the link between science and technology, and art and design.

Best of the Week: Inside the McLean Group Laboratory, Enhancing Omics Techniques

Best of the Week: Inside the McLean Group Laboratory, Enhancing Omics Techniques

April 19th 2024
Article

Here are the top five articles that the editors of LCGC International published this week.

lung cancer | Image Credit: © utah51 - stock.adobe.com

LC–MS/MS Array Created to Help Prognoses for Lung Cancer

April 16th 2024
Article

Scientists from the Netherlands created a new LC–MS/MS assay to test new small molecular inhibitors (SMIs) and their effectiveness in prognosing lung cancer.